Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia.
作者信息
Cunha B A
出版信息
Am J Med. 2001 Oct 1;111(5):412-3. doi: 10.1016/s0002-9343(01)00934-2.
Abstract
摘要
相似文献
1
Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia.
Am J Med. 2001 Oct 1;111(5):412-3. doi: 10.1016/s0002-9343(01)00934-2.
2
Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial.
Am J Med. 2001 Oct 1;111(5):367-74. doi: 10.1016/s0002-9343(01)00868-3.
3
Duration and route of antibiotic therapy in community-acquired pneumonia: switch and step-down therapy.
Semin Respir Infect. 1998 Mar;13(1):36-42.
4
Choosing antibiotics for community acquired pneumonia.
Indian Pediatr. 2003 Oct;40(10):958-64.
5
6
When to switch therapy in patients with severe community-acquired pneumonia.
Ann Intern Med. 2008 Apr 15;148(8):625; author reply 625-6. doi: 10.7326/0003-4819-148-8-200804150-00011.
7
How short can courses be in lower respiratory tract infections?
J Int Med Res. 2000;28 Suppl 1:37A-47A.
8
Switch therapy with beta-lactam/beta-lactamase inhibitors in patients with community-acquired pneumonia.
Ann Pharmacother. 1998 Jan;32(1):S22-6. doi: 10.1177/106002809803200106.
9
The use of fluoroquinolones as antiinfective transition-therapy agents in community-acquired pneumonia.
Pharmacotherapy. 2001 Jul;21(7 Pt 2):100S-104S. doi: 10.1592/phco.21.10.100s.34534.
10
A CAP on antibiotic duration.
Am J Respir Crit Care Med. 2006 Jul 1;174(1):3-5. doi: 10.1164/rccm.200604-535ED.
引用本文的文献
1
Association between initial antibiotic route and outcomes for children hospitalized with pneumonia.
J Hosp Med. 2025 Mar;20(3):238-247. doi: 10.1002/jhm.13516. Epub 2024 Oct 9.
2
Antibiotic route and outcomes for children hospitalized with pneumonia.
J Hosp Med. 2024 Aug;19(8):693-701. doi: 10.1002/jhm.13382. Epub 2024 Apr 28.
3
Necroptosis in Pneumonia: Therapeutic Strategies and Future Perspectives.
Viruses. 2024 Jan 7;16(1):94. doi: 10.3390/v16010094.
4
Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs).
Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1869-71. doi: 10.1007/s10096-014-2113-z. Epub 2014 May 18.
5
The atypical pneumonias: clinical diagnosis and importance.
Clin Microbiol Infect. 2006 May;12 Suppl 3:12-24. doi: 10.1111/j.1469-0691.2006.01393.x.
6
Empiric oral monotherapy for hospitalized patients with community-acquired pneumonia: an idea whose time has come.
Eur J Clin Microbiol Infect Dis. 2004 Feb;23(2):78-81. doi: 10.1007/s10096-003-1061-9. Epub 2004 Jan 15.
Zotero 插件